{"title":"预测老年肝硬化明显肝性脑病的简单评分模型:一项多中心回顾性队列研究。","authors":"Yuki Utakata, Takao Miwa, Masashi Aiba, Shinji Unome, Tatsunori Hanai, Kenji Imai, Yohei Shirakami, Koji Takai, Makoto Shiraki, Naoki Katsumura, Masahito Shimizu","doi":"10.1007/s11011-025-01691-x","DOIUrl":null,"url":null,"abstract":"<p><p>Identifying the risk of overt hepatic encephalopathy (OHE) in geriatric patients with cirrhosis remains challenging. This study aimed to investigate the independent factors for OHE development in geriatric cirrhosis and to establish a simple scoring model to identify individuals at risk for OHE. We conducted a retrospective review of geriatric patients with cirrhosis aged ≥ 80 years who were admitted between April 2006 and November 2022. Baseline parameters were assessed at the time of admission, and factors associated with OHE development were examined using Fine-Gray proportional hazards regression analysis, with mortality as a competing risk. Based on the factors associated with OHE development, a simple hepatic encephalopathy (sHE) score was calculated, and its efficacy was subsequently verified. Of the 270 patients analyzed, the median age was 83 years, and 63% were male. During a median follow-up of 1.8 years, 41 (15%) patients developed OHE and 120 (44%) patients died. Multivariable analysis revealed that serum albumin (sub-distribution hazard ratio [SHR], 0.51; 95% confidence interval [CI], 0.27-0.98; p = 0.042) and ammonia (SHR, 1.01; 95% CI, 1.00-1.02; p = 0.006) levels were independent factors for OHE development in geriatric cirrhosis. Based on the sHE score, the high-risk and intermediate-risk groups exhibited a high incidence of OHE, whereas those in the low-risk group rarely developed OHE. Serum albumin and ammonia levels were identified as independent risk factors for the development of OHE in geriatric cirrhosis. The sHE score was useful for stratifying the risk of OHE in the geriatric population.</p>","PeriodicalId":18685,"journal":{"name":"Metabolic brain disease","volume":"40 7","pages":"263"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12423195/pdf/","citationCount":"0","resultStr":"{\"title\":\"Simple scoring model for predicting overt hepatic encephalopathy in geriatric cirrhosis: A multicenter retrospective cohort study.\",\"authors\":\"Yuki Utakata, Takao Miwa, Masashi Aiba, Shinji Unome, Tatsunori Hanai, Kenji Imai, Yohei Shirakami, Koji Takai, Makoto Shiraki, Naoki Katsumura, Masahito Shimizu\",\"doi\":\"10.1007/s11011-025-01691-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Identifying the risk of overt hepatic encephalopathy (OHE) in geriatric patients with cirrhosis remains challenging. This study aimed to investigate the independent factors for OHE development in geriatric cirrhosis and to establish a simple scoring model to identify individuals at risk for OHE. We conducted a retrospective review of geriatric patients with cirrhosis aged ≥ 80 years who were admitted between April 2006 and November 2022. Baseline parameters were assessed at the time of admission, and factors associated with OHE development were examined using Fine-Gray proportional hazards regression analysis, with mortality as a competing risk. Based on the factors associated with OHE development, a simple hepatic encephalopathy (sHE) score was calculated, and its efficacy was subsequently verified. Of the 270 patients analyzed, the median age was 83 years, and 63% were male. During a median follow-up of 1.8 years, 41 (15%) patients developed OHE and 120 (44%) patients died. Multivariable analysis revealed that serum albumin (sub-distribution hazard ratio [SHR], 0.51; 95% confidence interval [CI], 0.27-0.98; p = 0.042) and ammonia (SHR, 1.01; 95% CI, 1.00-1.02; p = 0.006) levels were independent factors for OHE development in geriatric cirrhosis. Based on the sHE score, the high-risk and intermediate-risk groups exhibited a high incidence of OHE, whereas those in the low-risk group rarely developed OHE. Serum albumin and ammonia levels were identified as independent risk factors for the development of OHE in geriatric cirrhosis. The sHE score was useful for stratifying the risk of OHE in the geriatric population.</p>\",\"PeriodicalId\":18685,\"journal\":{\"name\":\"Metabolic brain disease\",\"volume\":\"40 7\",\"pages\":\"263\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12423195/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Metabolic brain disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11011-025-01691-x\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Metabolic brain disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11011-025-01691-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
摘要
确定老年肝硬化患者发生显性肝性脑病(OHE)的风险仍然具有挑战性。本研究旨在探讨老年肝硬化OHE发展的独立因素,并建立一个简单的评分模型来识别OHE风险个体。我们对2006年4月至2022年11月期间入院的年龄≥80岁的肝硬化老年患者进行了回顾性研究。在入院时评估基线参数,并使用Fine-Gray比例风险回归分析检查与OHE发展相关的因素,死亡率作为竞争风险。根据与OHE发展相关的因素,计算单纯性肝性脑病(sHE)评分,并随后验证其疗效。在分析的270例患者中,中位年龄为83岁,63%为男性。在中位1.8年的随访期间,41例(15%)患者发生OHE, 120例(44%)患者死亡。多变量分析显示,血清白蛋白(亚分布风险比[SHR], 0.51; 95%可信区间[CI], 0.27-0.98; p = 0.042)和氨(SHR, 1.01; 95% CI, 1.00-1.02; p = 0.006)水平是老年肝硬化OHE发生的独立因素。根据sHE评分,高危和中危组OHE发生率高,而低危组很少发生OHE。血清白蛋白和氨水平被确定为老年肝硬化OHE发展的独立危险因素。sHE评分对于老年人群OHE风险的分层是有用的。
Simple scoring model for predicting overt hepatic encephalopathy in geriatric cirrhosis: A multicenter retrospective cohort study.
Identifying the risk of overt hepatic encephalopathy (OHE) in geriatric patients with cirrhosis remains challenging. This study aimed to investigate the independent factors for OHE development in geriatric cirrhosis and to establish a simple scoring model to identify individuals at risk for OHE. We conducted a retrospective review of geriatric patients with cirrhosis aged ≥ 80 years who were admitted between April 2006 and November 2022. Baseline parameters were assessed at the time of admission, and factors associated with OHE development were examined using Fine-Gray proportional hazards regression analysis, with mortality as a competing risk. Based on the factors associated with OHE development, a simple hepatic encephalopathy (sHE) score was calculated, and its efficacy was subsequently verified. Of the 270 patients analyzed, the median age was 83 years, and 63% were male. During a median follow-up of 1.8 years, 41 (15%) patients developed OHE and 120 (44%) patients died. Multivariable analysis revealed that serum albumin (sub-distribution hazard ratio [SHR], 0.51; 95% confidence interval [CI], 0.27-0.98; p = 0.042) and ammonia (SHR, 1.01; 95% CI, 1.00-1.02; p = 0.006) levels were independent factors for OHE development in geriatric cirrhosis. Based on the sHE score, the high-risk and intermediate-risk groups exhibited a high incidence of OHE, whereas those in the low-risk group rarely developed OHE. Serum albumin and ammonia levels were identified as independent risk factors for the development of OHE in geriatric cirrhosis. The sHE score was useful for stratifying the risk of OHE in the geriatric population.
期刊介绍:
Metabolic Brain Disease serves as a forum for the publication of outstanding basic and clinical papers on all metabolic brain disease, including both human and animal studies. The journal publishes papers on the fundamental pathogenesis of these disorders and on related experimental and clinical techniques and methodologies. Metabolic Brain Disease is directed to physicians, neuroscientists, internists, psychiatrists, neurologists, pathologists, and others involved in the research and treatment of a broad range of metabolic brain disorders.